MentionFox
Home › funding signals › Numerion Labs, Inc.
Form D · on the record

Numerion Labs — $19.79M Form D filing, March 2026

Numerion Labs, Inc. filed a Form D with the Securities and Exchange Commission on 2026-03-19.

Numerion Labs, Inc. filed a Form D notice of an exempt securities offering with the SEC on March 19, 2026. Numerion Labs, Inc. was formerly named Atomwise Inc. The filing reports $19.79M sold. Its industry group is Biotechnology. It names Stephen Worland (Executive Officer, Director), Izhar Wallach (Director), Robert Mittendorff (Director) (SEC Form D, March 19, 2026).

In its own words: “Our AI superplatform explores chemical space for novel molecules, enhancing drug discovery using machine learning to uncover unseen potential.” (numerionlabs.ai, checked October 31, 2026)

125 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Andersen Aggregator LLC$1.9BBusiness services
AT Umbrella LLC$1.9BBusiness services
Legora, Inc.$221MAI and software
MD INVESTMENT LLC$169MBusiness services
Serval Inc.$149MAI and software
Check one company free

5 more Biotechnology raises in California, March 2026 ↓

Is this your company?

Key facts

Run the free check on Numerion Labs, Inc. →

Sell to companies like Numerion Labs, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Numerion Labs, Inc.

New Form D on file · 2026-03-19 · the record

$19.79M
raise on the record
D
filing
5
investors in
CALIFORNIA
based
Open the record →

What the record says

FilingForm D
Filed2026-03-19
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
BasedSAN FRANCISCO, CALIFORNIA
CIK1736153
Accession0001231919-26-000263

Pitching, partnering or investing alongside them? See who really runs and owns Numerion Labs, Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Numerion Labs, Inc., from the filings we hold.

More raises like this

Biotechnology raises by companies based in California, filed in March 2026, largest first.

What do you want to do with Numerion Labs, Inc.?

Get the full cited report on Numerion Labs, Inc.

What the filing shows about Numerion Labs, Inc.

  • 5 investors had already put money in when it filed.
  • The filing names 7 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Numerion Labs, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Numerion Labs, Inc.'s address as 250 Sutter St. Suite 650, San Francisco, CA 94108.

What the filing says

  • Offered: $35,000,000. Sold: $19,794,945. Left to sell: $15,205,055. (filing)
  • Investors: 5 had already invested. (filing)
  • Date of first sale: March 10, 2026. (filing)
  • Types of securities: Equity; Other: Offer and sale of Series D Preferred Stock and Common Stock issuable upon conversion thereof. Certain outstanding shares of Common Stock were exchanged for shares of a specific series of Issuer's Preferred Stock for no consideration.. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters (marked as an estimate). (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Numerion Labs, Inc. See pricing

Is Numerion Labs, Inc. a real, registered company?

Numerion Labs, Inc. is a registered filer with the SEC (CIK 1736153) and has filed since 2025-03-14. 2 filings are on record, the latest on 2026-03-19.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Numerion Labs, Inc.?

Numerion Labs, Inc.'s Form D of 2026-03-19 names Stephen Worland, Izhar Wallach, Robert Mittendorff and 4 more as its officers, directors or promoters.

How much has Numerion Labs, Inc. raised?

Its new offerings report $64.07M sold across 2 offerings, as its own filings state.

Filing history · 2 filings on this registrant
Form D · 2025-03-14 · $44.28MForm D · 2026-03-19 · $19.79M · this page 2025-03-14 2026-03-19

Each marker is one filing. The larger marker is the filing this page is about.

Biotechnology · by week
This raise, $19.79M, filed week of Mar 16

Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $19.79M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Numerion Labs, Inc.?

What the filing shows about Numerion Labs, Inc.

  • 5 investors had already put money in when it filed.
  • The filing names 7 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Numerion Labs, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Numerion Labs, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Numerion Labs, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Numerion Labs, Inc.. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Numerion Labs, Inc.: Raised $19.79M, Form D filed 2026-03-19
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/numerion-labs-inc-form-d-26000001
Last updated 2026-10-20
Primary record: SEC filing 1 · SEC filing 2
Numerion Labs raised $19.79M — SEC Form D filing, March 2026. MentionFox, 2026-10-20. https://mentionfox.com/funding/numerion-labs-inc-form-d-26000001